Table 2.

Study endpoints

		Incidence proportion, n (%)	Incidence rate, events per 100 patient-years (95% CI)
Primary outcomes	Major bleeding	19 (2.1%)	2.4 (1.4–3.7)
	All-cause mortality	8 (0.9%)	1.0 (0.4–2.0)
Secondary outcomes	Thromboembolic event	13 (1.4%)	1.6 (0.9–2.8)
	Non-major bleeding	142 (15.8%)	19.6 (16.5–23.1)

CI confidence interval